toxicity

A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum
J. V. Brown, M. A. Rettenmaier, K. L. Lopez, C. Graham, J. P. Micha, B. Goldstein

International Journal of Gynecologic Cancer Feb 2008, 18 (2) 249-254; DOI: 10.1111/j.1525-1438.2007.01001.x
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients
T. Susini, G. Amunni, E. Busi, A. Villanucci, C. Carriero, G. Taddei, M. Marchionni, G. Scarselli

International Journal of Gynecologic Cancer May 2007, 17 (3) 581-588; DOI: 10.1136/ijgc-00009577-200705000-00005
Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study
A. A. Garsa, R. S. Andrade, D. E. Heron, S. Beriwal, H. Kim, E. Brandner, G. Kuo, H. Chen, K. Gerszten, J. N. Yue, M. S. Huq, J. Lee, R. Lalonde, A. Wu

International Journal of Gynecologic Cancer Jan 2007, 17 (1) 55-60; DOI: 10.1111/j.1525-1438.2006.00743.x
Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix
C. H. Choi, T.-J. Kim, S.-J. Lee, J.-W. Lee, B.-G. Kim, J.-H. Lee, D.-S. Bae

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1157-1164; DOI: 10.1136/ijgc-00009577-200605000-00032
Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
T. Turan, O. Karacay, G. Tulunay, N. Boran, S. Koc, S. Bozok, M. F. Kose

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1432-1438; DOI: 10.1136/ijgc-00009577-200605000-00074
Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1–2, stage IC endometrial cancer
M. CENGIZ, A. K. SINGH, P. W. GRIGSBY

International Journal of Gynecologic Cancer Sep 2005, 15 (5) 926-931; DOI: 10.1136/ijgc-00009577-200509000-00034
Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma
B. Piura, A. Rabinovich

International Journal of Gynecologic Cancer Jun 2005, 15 (4) 612-617; DOI: 10.1136/ijgc-00009577-200507000-00006
Preliminary toxicity analysis of intraperitoneal carboplatin in combination with intravenous paclitaxel chemotherapy for patients with carcinoma of the ovary, peritoneum, or fallopian tube
K. Fujiwara, S. Suzuki, H. Ishikawa, T. Oda, E. Aotani, I. Kohno

International Journal of Gynecologic Cancer Apr 2005, 15 (3) 426-431; DOI: 10.1136/ijgc-00009577-200505000-00003
EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV)
F. Ghaemmaghami, M. Modares, M. Arab, N. Behtash, A. Z. Moosavi, N. Khanafshar, P. Hanjani

International Journal of Gynecologic Cancer Feb 2004, 14 (2) 360-365; DOI: 10.1136/ijgc-00009577-200403000-00025
Practical model-based dose-finding in phase I clinical trials: Methods based on toxicity
P. F. THALL, S.-J. LEE

International Journal of Gynecologic Cancer May 2003, 13 (3) 251-261; DOI: 10.1136/ijgc-00009577-200305000-00001

Main menu

toxicity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

toxicity

Pages